Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
Thomas Jefferson University
BeOne Medicines
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Nurix Therapeutics, Inc.
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Calibr, a division of Scripps Research
Dana-Farber Cancer Institute
AbbVie
Nurix Therapeutics, Inc.
Cellectar Biosciences, Inc.
University of Chicago
Gilead Sciences
University of Washington
Eli Lilly and Company
Mayo Clinic
Dana-Farber Cancer Institute
Ascentage Pharma Group Inc.
Newave Pharmaceutical Inc
Schrödinger, Inc.
Dana-Farber Cancer Institute
City of Hope Medical Center
BeOne Medicines
iOMEDICO AG
Eli Lilly and Company
Acerta Pharma BV
Carna Biosciences, Inc.
BeOne Medicines
Seoul National University Hospital
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
City of Hope Medical Center
Accutar Biotechnology Inc
iOMEDICO AG
Northwell Health
Boryung Pharmaceutical Co., Ltd
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Memorial Sloan Kettering Cancer Center
Stanford University
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
University of Maryland, Baltimore
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Bio-Path Holdings, Inc.